SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...
YIWU, China, Jan. 16, 2026 /PRNewswire/ -- Yiwugo.com, the official website of the Yiwu Commodity Market, is the largest commodity wholesale market in the...
Marking a New Phase in Its Omnichannel Expansion HOUSTON, Jan. 16, 2026 /PRNewswire/ -- VEVOR, a global home improvement brand, today announced the opening...